<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03874910</url>
  </required_header>
  <id_info>
    <org_study_id>0115-18-HYMC</org_study_id>
    <nct_id>NCT03874910</nct_id>
  </id_info>
  <brief_title>Pathology Analysis of OPMD Patient Myotomies</brief_title>
  <official_title>Pathology Analysis of OPMD Patient Myotomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to characterize the effect of OPMD mutation on muscle function. Muscle samples
      will be received from oculopharyngeal muscular dystrophy (OPMD) patients who undergo
      cricopharyngeal muscle-cutting surgery, as part of their routine healthcare and treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 19, 2019</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of genes that show changes in RNA profile, measured by sequencing.</measure>
    <time_frame>Data will be collected within four years.</time_frame>
    <description>RNA profile analysis of OPMD muscle samples will be compared to unaffected muscle samples using sequencing to identify gene numbers.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of genes that show changes in protein profile, measured by SDS page.</measure>
    <time_frame>Data will be collected within four years.</time_frame>
    <description>Protein profile analysis of OPMD muscle samples will be compared to unaffected muscle samples to identify gene numbers using SDS page.</description>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Oculopharyngeal Muscular Dystrophy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who suffer from oculopharyngeal muscular dystrophy (OPMD).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OPMD patients both male and female.

          -  OPMD patients between the ages 18-70 years.

          -  OPMD patients who are referred to the cricopharyngeal muscle-cutting surgery as part
             of their usual treatment.

        Exclusion Criteria:

        â€¢ OPMD patients not referred to the cricopharyngeal muscle-cutting surgery as part of their
        usual treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Itzhak Braverman, Doctor (MD)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillel Yaffe Medical Center, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Itzhak Braverman, Doctor (MD)</last_name>
    <phone>+972-4-6304549</phone>
    <phone_ext>+97246304549</phone_ext>
    <email>braverman@hy.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilana Alony, Mrs</last_name>
      <phone>+972-52-3747719</phone>
      <phone_ext>+97246304549</phone_ext>
      <email>IlanaA@hy.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Itzhak Braverman, Doctor (MD)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2019</study_first_posted>
  <last_update_submitted>March 19, 2019</last_update_submitted>
  <last_update_submitted_qc>March 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Oculopharyngeal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

